SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

Morgan Stanley Upgrades Eli Lilly to Overweight, Announces $176 Price Target

Morgan Stanley analyst David Risinger upgrades Eli Lilly (NYSE:LLY) from Equal-Weight to Overweight and announces $176 price target.

· 09/03/2020 05:50
Morgan Stanley analyst David Risinger upgrades Eli Lilly (NYSE:LLY) from Equal-Weight to Overweight and announces $176 price target.